San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Tease photo

Astute Medical Inc. Receives FDA Clearance for Biomarker-Based Immunoassay

San Diego-based Astute Medical Inc. today announced that it has received clearance from the Food and Drug Administration to commence sales of its first biomarker-based immunoassay, NephroCheck.

Tease photo

ResMed, APEX Settle Patent Disputes

San Diego--based ResMed Inc. and APEX Medical Corp. have agreed to a confidential settlement resolving their outstanding patent disputes.

Tease photo

Company Develops Prototype for Treatment of Rare Skin Diseases

Biotech: The Device Is a Less Expensive Solution For Incurable Skin Disorders

Martyn Gross has suffered from psoriasis for most of his life, particularly on the difficult-to-treat regions of the hand and feet. After years of trying costly and ineffective treatments from uncomfortable phototherapy sessions in cold medical facilities to topical creams that wash off too easily, Gross decided to develop a handheld light therapy device to treat himself at home.

Tease photo

Targeted Medicine Changes Clinical Trials

HEALTH: Sequencing and Analytics Part of Process

Recent trends in biotech research point to faster, more efficient and less costly drug development for pharmaceutical companies.

Ajinomoto Althea Receives OK for Testing Drugs for European Market

San Diego-based Ajinomoto Althea Inc., a biopharmaceutical contract development and manufacturing company, has received clearance to test its commercial drug products for the European market.

Tease photo

Mirati Begins Phase One of Trials for Tumor Treatment

Mirati Therapeutics Inc. announced that the first patient has been dosed in its phase one clinical study for the treatment of patients with advanced solid tumors.

Tease photo

Halozyme Drug Candidate Granted Fast Track Status

Halozyme Therapeutics Inc. announced that the Food and Drug Administration has granted Fast Track designation for its program investigating a treatment for patients with metastatic pancreatic cancer.

Tease photo

RuiYi Inc. Names Saad to CFO Position

RuiYi Inc. announced today the appointment of Mark Saad as chief financial officer.

Tease photo

BioLegend Acquires Antibody Products Business Unit From Covance

San Diego-based BioLegend Inc. acquired the shares of Covance Antibody Services Inc., a business unit of Massachusetts-based Covance Inc., on August 29.

Tease photo

Arena Pharmaceuticals' Drug Candidate Granted Orphan Status From FDA

Arena Pharmaceuticals Inc. announced that the Food and Drug Administration has granted orphan drug status to the company’s drug candidate for the treatment of pulmonary arterial hypertension.

Tease photo

Proposition 45 Being Opposed By Insurers

HEALTH: Govt. Would Get Veto Power on Rate Increases

Health insurance companies may suffer a caustic blow by a currently popular ballot initiative that would expand the state’s authority to regulate health insurance rates.

Seragon Announces Closing of Its Acquisition By Genentech

San Diego-based Seragon Pharmaceuticals Inc. today announced the closing of its acquisition by Genentech Inc., a member of the Roche Group.

Mapp Biopharmaceutical CEO Discusses Ebola Fight

The elusive CEO of Mapp Biopharmaceutical Inc., the company that delivered an experimental Ebola drug to American aid workers in West Africa, spoke at a panel discussion yesterday afternoon hosted by The Scripps Research Institute.

Tocagen Fills Key Positions in Clinical Development

San Diego-based Tocagen Inc. announced Wayne Saville has been named vice president of clinical development and Mary Rose Keller has been named vice president of clinical operations.